Palisade Bio, Inc. · NASDAQ:PALI
Jones Mitchell Lawrence sold 51,880 Palisade Bio, Inc. shares (Form 4)
Traded Jul 6 to Jul 7, 2026 · Filed Jul 8, 2026
From Jul 6 to Jul 7, 2026, Jones Mitchell Lawrence (Chief Medical Officer) sold 51,880 Palisade Bio, Inc. shares at US$2.05 for US$106K, leaving 94,009 shares. Filed Jul 8, 2026 (Form 4).
- Sold
- 51,880 shares
- Price
- US$2.05
- Value
- US$106K
- Holding after
- 94,009 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Option exercise | 131,167 | 145,889 | Direct | |
| Jul 7, 2026 | Common Stock | Sale | 51,880 | US$2.05 | 94,009 | Direct |
Source
Related
- Palisade Bio, Inc.
- Jones Mitchell Lawrence
- Palisade Bio, Inc. shareholders
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Form 4 · Finley John David · Aug 21, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026